FLT4 and inflammatory breast carcinoma: Targeting lymphangiogenesis through the VEGF-C/VEGF-D/VEGFR-3 signalling system would be a reasonable therapeutic approach for IBC, although it will need to be further examined in both preclinical and clinical studies.